These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. State of the art in non-animal approaches for skin sensitization testing: from individual test methods towards testing strategies. Ezendam J; Braakhuis HM; Vandebriel RJ Arch Toxicol; 2016 Dec; 90(12):2861-2883. PubMed ID: 27629427 [TBL] [Abstract][Full Text] [Related]
4. Development of a next generation risk assessment framework for the evaluation of skin sensitisation of cosmetic ingredients. Gilmour N; Kern PS; Alépée N; Boislève F; Bury D; Clouet E; Hirota M; Hoffmann S; Kühnl J; Lalko JF; Mewes K; Miyazawa M; Nishida H; Osmani A; Petersohn D; Sekine S; van Vliet E; Klaric M Regul Toxicol Pharmacol; 2020 Oct; 116():104721. PubMed ID: 32645429 [TBL] [Abstract][Full Text] [Related]
5. Assessment of a defined approach based on a stacking prediction model to identify skin sensitization hazard. Tourneix F; Alépée N; Detroyer A; Eilstein J; Martinozzi Teissier S; Nardelli L; Noçairi H; Pauloin T; Piroird C; Del Bufalo A Toxicol In Vitro; 2019 Oct; 60():134-143. PubMed ID: 31100378 [TBL] [Abstract][Full Text] [Related]
6. Applicability of an Integrated Testing Strategy consisting of in silico, in chemico and in vitro assays for evaluating the skin sensitization potencies of isocyanates. Ohtake T; Maeda Y; Hayashi T; Yamanaka H; Nakai M; Takeyoshi M Toxicology; 2018 Jan; 393():9-14. PubMed ID: 29100879 [TBL] [Abstract][Full Text] [Related]
7. Towards AOP application--implementation of an integrated approach to testing and assessment (IATA) into a pipeline tool for skin sensitization. Patlewicz G; Kuseva C; Kesova A; Popova I; Zhechev T; Pavlov T; Roberts DW; Mekenyan O Regul Toxicol Pharmacol; 2014 Aug; 69(3):529-45. PubMed ID: 24928565 [TBL] [Abstract][Full Text] [Related]
8. Computer models versus reality: how well do in silico models currently predict the sensitization potential of a substance. Teubner W; Mehling A; Schuster PX; Guth K; Worth A; Burton J; van Ravenzwaay B; Landsiedel R Regul Toxicol Pharmacol; 2013 Dec; 67(3):468-85. PubMed ID: 24090701 [TBL] [Abstract][Full Text] [Related]
9. A defined approach for predicting skin sensitisation hazard and potency based on the guided integration of in silico, in chemico and in vitro data using exclusion criteria. Macmillan DS; Chilton ML Regul Toxicol Pharmacol; 2019 Feb; 101():35-47. PubMed ID: 30439387 [TBL] [Abstract][Full Text] [Related]
10. The 21st Century movement within the area of skin sensitization assessment: From the animal context towards current human-relevant in vitro solutions. de Ávila RI; Lindstedt M; Valadares MC Regul Toxicol Pharmacol; 2019 Nov; 108():104445. PubMed ID: 31430506 [TBL] [Abstract][Full Text] [Related]
11. An in vitro skin sensitization assay termed EpiSensA for broad sets of chemicals including lipophilic chemicals and pre/pro-haptens. Saito K; Takenouchi O; Nukada Y; Miyazawa M; Sakaguchi H Toxicol In Vitro; 2017 Apr; 40():11-25. PubMed ID: 27965148 [TBL] [Abstract][Full Text] [Related]
12. Development of a new in vitro skin sensitization assay (Epidermal Sensitization Assay; EpiSensA) using reconstructed human epidermis. Saito K; Nukada Y; Takenouchi O; Miyazawa M; Sakaguchi H; Nishiyama N Toxicol In Vitro; 2013 Dec; 27(8):2213-24. PubMed ID: 23999411 [TBL] [Abstract][Full Text] [Related]
14. Application of IATA - A case study in evaluating the global and local performance of a Bayesian network model for skin sensitization. Fitzpatrick JM; Patlewicz G SAR QSAR Environ Res; 2017 Apr; 28(4):297-310. PubMed ID: 28423913 [TBL] [Abstract][Full Text] [Related]
15. An in vitro human skin test for assessing sensitization potential. Ahmed SS; Wang XN; Fielding M; Kerry A; Dickinson I; Munuswamy R; Kimber I; Dickinson AM J Appl Toxicol; 2016 May; 36(5):669-84. PubMed ID: 26251951 [TBL] [Abstract][Full Text] [Related]
16. Lymphocyte surface markers and cytokines are suitable for detection and potency assessment of skin-sensitizing chemicals in an in vitro model of allergic contact dermatitis: the LCSA-ly. Frombach J; Sonnenburg A; Krapohl BD; Zuberbier T; Peiser M; Stahlmann R; Schreiner M Arch Toxicol; 2018 Apr; 92(4):1495-1505. PubMed ID: 29380012 [TBL] [Abstract][Full Text] [Related]
17. Mechanistic understanding of dendritic cell activation in skin sensitization: additional evidences to support potency classification. Galbiati V; Marinovich M; Corsini E Toxicol Lett; 2020 Apr; 322():50-57. PubMed ID: 31958493 [TBL] [Abstract][Full Text] [Related]
19. A data-based exploration of the adverse outcome pathway for skin sensitization points to the necessary requirements for its prediction with alternative methods. Benigni R; Bossa C; Tcheremenskaia O Regul Toxicol Pharmacol; 2016 Jul; 78():45-52. PubMed ID: 27090483 [TBL] [Abstract][Full Text] [Related]
20. Identification of pre- and pro-haptens with a β-galactosidase-expressing E. coli culture system for skin sensitization. Nepal MR; Kang MJ; Kim GH; Cha DH; Nam DH; Jeong TC Toxicol Lett; 2019 May; 305():81-93. PubMed ID: 30711672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]